Therapy Dog Visits for Patients Hospitalized With Traumatic Injuries

NCT ID: NCT06812247

Last Updated: 2025-06-06

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

80 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-06-04

Study Completion Date

2026-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Animal assisted therapy (AAT) with dogs has been shown to be beneficial for a wide range of patients with both acute and chronic illnesses, including spinal cord injuries, heart failure, myocardial infarctions, strokes, cancer, post-traumatic stress disorder, and depression. Studies have also demonstrated that even in healthy adults, the presence of dogs is associated with physiologic changes such as increased pain threshold, decreased blood pressure, and decreased heart rate. However, few studies have investigated the role of AAT in the post-operative course in adults. This study will investigate the impact of therapy dog visits on pain and anxiety scores for trauma patients at Boston Medical Center (BMC).

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This study will be a randomized control design. Within 48 hours of admission, the study team will approach eligible patients admitted to the inpatient trauma service to discuss the study and obtain informed consent from patients expected to be admitted for 3-7 days. Consenting patients will be randomized to either a) participate in 2-3 ten-minute dog visits or b) receive 2-3 ten-minute visits with a handler alone. Within 24 hours after the last anticipated study visit, a member of the study team will administer a survey to assess participants' pain, depression, anxiety, mood, and emotional quality of life.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Trauma Injury Depression Anxiety Anger Pain

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Therapy dog visits

Participants randomized into this arm will receive visits from a therapy dog and their handler during hospitalization.

Group Type EXPERIMENTAL

Therapy dog visits

Intervention Type OTHER

2-3 ten-minute visits by a trained therapy dog and the dog's handler

Dog handler visits

Participants randomized into this arm will receive visits from a dog handler during hospitalization.

Group Type ACTIVE_COMPARATOR

Dog handler visits

Intervention Type OTHER

2-3 ten-minute visits by a dog handler

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Therapy dog visits

2-3 ten-minute visits by a trained therapy dog and the dog's handler

Intervention Type OTHER

Dog handler visits

2-3 ten-minute visits by a dog handler

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients admitted to the Trauma and Acute Care Surgery (TACS) service following a trauma
* English or Spanish speaking
* Able to provide informed consent

Exclusion Criteria

* Fear of dogs, allergy to dogs
* Immunocompromised
* Contact precautions
* Delirious, intubated, or otherwise unable to consent
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Boston Medical Center Healing Pups Program

UNKNOWN

Sponsor Role collaborator

Boston Medical Center

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Sabrina Sanchez, MD MPH

Role: PRINCIPAL_INVESTIGATOR

Boston Medical Center

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Boston Medical Center, Trauma Inpatient Service

Boston, Massachusetts, United States

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

United States

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Sabrina Sanchez, MD MPH

Role: CONTACT

617 414 4861

Sara Myers, MD

Role: CONTACT

617 638 9191

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Sabrina Sanchez, MD MPH

Role: primary

617-414-4861

Sara Myers, MD

Role: backup

617 638 9191

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

H45457

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Psychosomatic Risk Screening
NCT06651164 COMPLETED NA
Building Resilience In Caregivers of Trauma Survivors
NCT04293016 ACTIVE_NOT_RECRUITING NA